{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:27:48Z","timestamp":1784280468317,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,9,22]],"date-time":"2011-09-22T00:00:00Z","timestamp":1316649600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10875-011-9589-4","type":"journal-article","created":{"date-parts":[[2011,9,21]],"date-time":"2011-09-21T14:06:57Z","timestamp":1316614017000},"page":"1045-1053","source":"Crossref","is-referenced-by-count":52,"title":["Developmental, Malignancy-Related, and Cross-Species Analysis of Eosinophil, Mast Cell, and Basophil Siglec-8 Expression"],"prefix":"10.1007","volume":"31","author":[{"given":"Sherry A.","family":"Hudson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El-Bdaoui","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Crocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce S.","family":"Bochner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,22]]},"reference":[{"key":"9589_CR1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1074\/jbc.275.2.861","volume":"275","author":"H Floyd","year":"2000","unstructured":"Floyd H, Ni J, Cornish AL, Zeng Z, Liu D, Carter KC, et al. Siglec-8: a novel eosinophil-specific member of the immunoglobulin superfamily. J Biol Chem. 2000;275:861\u20136.","journal-title":"J Biol Chem"},{"key":"9589_CR2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1067\/mai.2000.107127","volume":"105","author":"KK Kikly","year":"2000","unstructured":"Kikly KK, Bochner BS, Freeman S, Tan KB, Gallagher KT, D'Alessio K, et al. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells and basophils. J Allergy Clin Immunol. 2000;105:1093\u2013100.","journal-title":"J Allergy Clin Immunol"},{"key":"9589_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2222.2008.03173.x","volume":"39","author":"BS Bochner","year":"2009","unstructured":"Bochner BS. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors. Clin Exp Allergy. 2009;39:317\u201324.","journal-title":"Clin Exp Allergy"},{"key":"9589_CR4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/jpet.109.152439","volume":"330","author":"SA Hudson","year":"2009","unstructured":"Hudson SA, Bovin N, Schnaar RL, Crocker PR, Bochner BS. Eosinophil-selective binding and pro-apoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis X. J Pharmacol Exp Ther. 2009;330:608\u201312.","journal-title":"J Pharmacol Exp Ther"},{"key":"9589_CR5","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1182\/blood-2002-10-3058","volume":"101","author":"E Nutku","year":"2003","unstructured":"Nutku E, Aizawa H, Hudson SA, Bochner BS. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood. 2003;101:5014\u201320.","journal-title":"Blood"},{"key":"9589_CR6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.bbrc.2005.08.202","volume":"336","author":"E Nutku","year":"2005","unstructured":"Nutku E, Hudson SA, Bochner BS. Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury. Biochem Biophys Res Commun. 2005;336:918\u201324.","journal-title":"Biochem Biophys Res Commun"},{"key":"9589_CR7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1165\/rcmb.2007-0154OC","volume":"38","author":"E Nutku-Bilir","year":"2008","unstructured":"Nutku-Bilir E, Hudson SA, Bochner BS. Interleukin-5 priming of human eosinophils alters Siglec-8 mediated apoptosis pathways. Am J Respir Cell Mol Biol. 2008;38:121\u20134.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9589_CR8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaci.2007.10.004","volume":"121","author":"H Yokoi","year":"2008","unstructured":"Yokoi H, Choi OH, Hubbard W, Lee H-S, Canning BJ, Lee HH, et al. Inhibition of Fc\u03b5RI-dependent mediator release and calcium flux from human mast cells by Siglec-8 engagement. J Allergy Clin Immunol. 2008;121:499\u2013505.","journal-title":"J Allergy Clin Immunol"},{"key":"9589_CR9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/glycob\/cwi097","volume":"15","author":"H Tateno","year":"2005","unstructured":"Tateno H, Crocker PR, Paulson JC. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand. Glycobiology. 2005;15:1125\u201335.","journal-title":"Glycobiology"},{"key":"9589_CR10","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1093\/glycob\/cwj008","volume":"16","author":"A Varki","year":"2006","unstructured":"Varki A, Angata T. Siglecs\u2014the major sub-family of I-type lectins. Glycobiology. 2006;16:1R\u201327R.","journal-title":"Glycobiology"},{"key":"9589_CR11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1465-9921-11-154","volume":"11","author":"JY Cho","year":"2010","unstructured":"Cho JY, Song DJ, Pham A, Rosenthal P, Miller M, Dayan S, et al. Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13. Respir Res. 2010;11:154.","journal-title":"Respir Res"},{"key":"9589_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clim.2008.11.009","volume":"131","author":"DJ Song","year":"2009","unstructured":"Song DJ, Cho JY, Miller M, Strangman W, Zhang M, Varki A, et al. Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model. Clin Immunol. 2009;131:157\u201369.","journal-title":"Clin Immunol"},{"key":"9589_CR13","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.4049\/jimmunol.0801421","volume":"183","author":"DJ Song","year":"2009","unstructured":"Song DJ, Cho JY, Lee SY, Miller M, Rosenthal P, Soroosh P, et al. Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling. J Immunol. 2009;183:5333\u201341.","journal-title":"J Immunol"},{"key":"9589_CR14","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1398-9995.2008.01709.x","volume":"63","author":"N Zimmermann","year":"2008","unstructured":"Zimmermann N, McBride ML, Yamada Y, Hudson SA, Jones C, Cromie KD, et al. Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy. 2008;63:1156\u201363.","journal-title":"Allergy"},{"key":"9589_CR15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1398-9995.2006.01133.x","volume":"61","author":"H Yokoi","year":"2006","unstructured":"Yokoi H, Myers A, Matsumoto K, Crocker PR, Saito H, Bochner BS. Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells. Allergy. 2006;61:769\u201376.","journal-title":"Allergy"},{"key":"9589_CR16","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.4049\/jimmunol.181.6.4004","volume":"181","author":"KD Dyer","year":"2008","unstructured":"Dyer KD, Moser JM, Czapiga M, Siegel SJ, Percopo CM, Rosenberg HF. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol. 2008;181:4004\u20139.","journal-title":"J Immunol"},{"key":"9589_CR17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-2427(97)00154-2","volume":"61","author":"I Lilliehook","year":"1998","unstructured":"Lilliehook I, Johannisson A, Hakansson L. Expression of adhesion and Fc\u03b3-receptors on canine blood eosinophils and neutrophils studied by anti-human monoclonal antibodies. Vet Immunol Immunopathol. 1998;61:181\u201393.","journal-title":"Vet Immunol Immunopathol"},{"key":"9589_CR18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood-2008-02-139741","volume":"113","author":"R Bedi","year":"2009","unstructured":"Bedi R, Du J, Sharma AK, Gomes I, Ackerman SJ. Human C\/EBP-epsilon activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation. Blood. 2009;113:317\u201327.","journal-title":"Blood"},{"key":"9589_CR19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.imlet.2007.02.003","volume":"109","author":"I Mirkina","year":"2007","unstructured":"Mirkina I, Schweighoffer T, Kricek F. Inhibition of human cord blood-derived mast cell responses by anti-Fc\u03b5RI mAb 15\/1 versus anti-IgE omalizumab. Immunol Lett. 2007;109:120\u20138.","journal-title":"Immunol Lett"},{"key":"9589_CR20","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1182\/blood-2008-08-175190","volume":"114","author":"KJ Aichberger","year":"2009","unstructured":"Aichberger KJ, Gleixner KV, Mirkina I, Cerny-Reiterer S, Peter B, Ferenc V, et al. Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs. Blood. 2009;114:5342\u201351.","journal-title":"Blood"},{"key":"9589_CR21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/stem.160016","volume":"16","author":"MA Baumann","year":"1998","unstructured":"Baumann MA, Paul CC. The AML14 and AML14.3D10 cell lines: a long-overdue model for the study of eosinophils and more. Stem Cells. 1998;16:16\u201324.","journal-title":"Stem Cells"},{"key":"9589_CR22","doi-asserted-by":"crossref","first-page":"43481","DOI":"10.1074\/jbc.M204777200","volume":"277","author":"J Du","year":"2002","unstructured":"Du J, Stankiewicz MJ, Liu Y, Xi Q, Schmitz JE, Lekstrom-Himes JA, et al. Novel combinatorial interactions of GATA-1, PU.1, and C\/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. J Biol Chem. 2002;277:43481\u201394.","journal-title":"J Biol Chem"},{"key":"9589_CR23","doi-asserted-by":"crossref","first-page":"33167","DOI":"10.1074\/jbc.M003655200","volume":"275","author":"J Du","year":"2000","unstructured":"Du J, Alsayed YM, Xin F, Ackerman SJ, Platanias LC. Engagement of the CrkL adapter in interleukin-5 signaling in eosinophils. J Biol Chem. 2000;275:33167\u201375.","journal-title":"J Biol Chem"},{"key":"9589_CR24","first-page":"32","volume-title":"World Health Organization (WHO) classification of tumours pathology & genetics tumours of haematopoietic and lymphoid tissues","author":"J Vardiman","year":"2008","unstructured":"Vardiman J, Melo J, Baccarani M, Thiele J. Chronic myelogenous leukemia, BCR\/ABL1 positive. In: Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, et al., editors. World Health Organization (WHO) classification of tumours pathology & genetics tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 32\u20137."},{"key":"9589_CR25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1399-3038.2010.01003.x","volume":"21","author":"AK Ellis","year":"2010","unstructured":"Ellis AK, Ackerman SJ, Crawford L, Du J, Bedi R, Denburg JA. Cord blood molecular biomarkers of eosinophilopoiesis: kinetic analysis of GATA-1, MBP1 and IL-5R alpha mRNA expression. Pediatr Allergy Immunol. 2010;21:640\u20138.","journal-title":"Pediatr Allergy Immunol"},{"key":"9589_CR26","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.4049\/jimmunol.180.8.5466","volume":"180","author":"M Mayerhofer","year":"2008","unstructured":"Mayerhofer M, Gleixner KV, Hoelbl A, Florian S, Hoermann G, Aichberger KJ, et al. Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens. J Immunol. 2008;180:5466\u201376.","journal-title":"J Immunol"},{"key":"9589_CR27","doi-asserted-by":"crossref","first-page":"45128","DOI":"10.1074\/jbc.M108573200","volume":"276","author":"T Angata","year":"2001","unstructured":"Angata T, Hingorani R, Varki NM, Varki A. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters. J Biol Chem. 2001;276:45128\u201336.","journal-title":"J Biol Chem"},{"key":"9589_CR28","doi-asserted-by":"crossref","first-page":"13251","DOI":"10.1073\/pnas.0404833101","volume":"101","author":"T Angata","year":"2004","unstructured":"Angata T, Margulies EH, Green ED, Varki A. Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms. Proc Natl Acad Sci USA. 2004;101:13251\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9589_CR29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00251-009-0372-0","volume":"61","author":"H Cao","year":"2009","unstructured":"Cao H, de Bono B, Belov K, Wong ES, Trowsdale J, Barrow AD. Comparative genomics indicates the mammalian CD33rSiglec locus evolved by an ancient large-scale inverse duplication and suggests all Siglecs share a common ancestral region. Immunogenetics. 2009;61:401\u201317.","journal-title":"Immunogenetics"},{"key":"9589_CR30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.tips.2009.02.005","volume":"30","author":"MK O'Reilly","year":"2009","unstructured":"O'Reilly MK, Paulson JC. Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci. 2009;30:240\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"9589_CR31","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1182\/blood-2009-12-257386","volume":"115","author":"WC Chen","year":"2010","unstructured":"Chen WC, Completo GC, Sigal DS, Crocker PR, Saven A, Paulson JC. In vivo targeting of B-cell lymphoma with glycan ligands of CD22. Blood. 2010;115:4778\u201386.","journal-title":"Blood"},{"key":"9589_CR32","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1172\/JCI45685","volume":"121","author":"L Kardava","year":"2011","unstructured":"Kardava L, Moir S, Wang W, Ho J, Buckner CM, Posada JG, et al. Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. J Clin Invest. 2011;121:2614\u201324.","journal-title":"J Clin Invest"},{"key":"9589_CR33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-4-431-88315-9_19","volume-title":"Allergy frontiers: classification and pathomechanisms","author":"S Gunten von","year":"2009","unstructured":"von Gunten S, Bochner BS. Expression and function of Siglec-8 in human eosinophils, basophils and mast cells. In: Pawankar R, Holgate S, Rosenwasser LJ, editors. Allergy frontiers: classification and pathomechanisms. Tokyo: Springer; 2009. p. 297\u2013313."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9589-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-011-9589-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9589-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:14:47Z","timestamp":1559261687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-011-9589-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,22]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9589"],"URL":"https:\/\/doi.org\/10.1007\/s10875-011-9589-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,22]]}}}